amygdalin has been researched along with Ascites in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attia, AA; El-Magd, MA; El-Naggar, SA; Eldiasty, JG; Elmetwalli, A; Mosallam, SAE; Nasser, HM; Salama, AF | 1 |
| Abo Gazia, MM; Hafez, E; Mutar, TF; Salem, SB; Tousson, E | 1 |
2 other study(ies) available for amygdalin and Ascites
| Article | Year |
|---|---|
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage.
Topics: Amygdalin; Animals; Antioxidants; Ascites; Carcinoma, Ehrlich Tumor; Liver; Matrix Metalloproteinase 9; Mice; Neoplasms; NF-E2-Related Factor 2; Sorafenib; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2022 |
Hepatic ameliorative role of vitamin B17 against Ehrlich ascites carcinoma-induced liver toxicity.
Topics: Amygdalin; Animals; Antineoplastic Agents, Phytogenic; Ascites; Carcinoma, Ehrlich Tumor; Female; Liver Neoplasms; Mice; Vitamin B Complex | 2020 |